Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.

Cancer cell | 2018

Cyclin dependent kinase 4/6 (CDK4/6) inhibitors (CDK4/6i) are effective in breast cancer; however, drug resistance is frequently encountered and poorly understood. We conducted a genomic analysis of 348 estrogen receptor-positive (ER+) breast cancers treated with CDK4/6i and identified loss-of-function mutations affecting FAT1 and RB1 linked to drug resistance. FAT1 loss led to marked elevations in CDK6, the suppression of which restored sensitivity to CDK4/6i. The induction of CDK6 was mediated by the Hippo pathway with accumulation of YAP and TAZ transcription factors on the CDK6 promoter. Genomic alterations in other Hippo pathway components were also found to promote CDK4/6i resistance. These findings uncover a tumor suppressor function of Hippo signaling in ER+ breast cancer and establish FAT1 loss as a mechanism of resistance to CDK4/6i.

Pubmed ID: 30537512 RIS Download

Research resources used in this publication

Associated grants

  • Agency: NIDCR NIH HHS, United States
    Id: K08 DE024774
  • Agency: NCI NIH HHS, United States
    Id: P30 CA008748
  • Agency: NCI NIH HHS, United States
    Id: R01 CA234361
  • Agency: NIDCR NIH HHS, United States
    Id: R01 DE027738

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


ATCC (tool)

RRID:SCR_001672

Global nonprofit biological resource center (BRC) and research organization that provides biological products, technical services and educational programs to private industry, government and academic organizations. Its mission is to acquire, authenticate, preserve, develop and distribute biological materials, information, technology, intellectual property and standards for the advancement and application of scientific knowledge. The primary purpose of ATCC is to use its resources and experience as a BRC to become the world leader in standard biological reference materials management, intellectual property resource management and translational research as applied to biomaterial development, standardization and certification. ATCC characterizes cell lines, bacteria, viruses, fungi and protozoa, as well as develops and evaluates assays and techniques for validating research resources and preserving and distributing biological materials to the public and private sector research communities.

View all literature mentions

Adobe Illustrator (tool)

RRID:SCR_010279

Vector graphics software to create digital graphics, illustrations, and typography for several types of media: print, web, interactive, video, and mobile.

View all literature mentions

cBioPortal (tool)

RRID:SCR_014555

A portal that provides visualization, analysis and download of large-scale cancer genomics data sets.

View all literature mentions

ggplot2 (tool)

RRID:SCR_014601

Open source software package for statistical programming language R to create plots based on grammar of graphics. Used for data visualization to break up graphs into semantic components such as scales and layers.

View all literature mentions

OncoKB (tool)

RRID:SCR_014782

Precision oncology knowledge base which contains information about the effects and treatment implications of specific cancer gene alterations. OncoKB contains detailed information about specific alterations in 418 cancer genes. Each variant entry contains biological effect, prevalence, prognostic information, and treatment implications. Information is curated from various sources, such as guidelines from the FDA, ClinicalTrials.gov, and scientific literature by a network of clinical fellows, research fellows, and faculty members at Memorial Sloan Kettering Cancer Center.

View all literature mentions

Beta-Tubulin Antibody (antibody)

RRID:AB_2210545

This polyclonal targets Beta-Tubulin

View all literature mentions

β-Actin (13E5) Rabbit mAb (antibody)

RRID:AB_2223172

This monoclonal targets beta-Actin

View all literature mentions

CDK4 (D9G3E) Rabbit mAb (antibody)

RRID:AB_2631166

This monoclonal targets CDK4

View all literature mentions

Phospho-Rb (Ser780) (D59B7) Rabbit mAb (antibody)

RRID:AB_10950972

This monoclonal targets Phospho-Rb (Ser780) (D59B7) Rabbit mAb

View all literature mentions

LATS1 (C66B5) Rabbit mAb (antibody)

RRID:AB_2133513

This monoclonal targets LATS1

View all literature mentions

Survivin (71G4B7) Rabbit mAb (antibody)

RRID:AB_2063948

This recombinant monoclonal targets Survivin

View all literature mentions

Anti-Mst1, phospho (Thr183) / Mst2, phospho (Thr180) Antibody, Unconjugated (antibody)

RRID:AB_330269

This unknown targets Mst1, phospho (Thr183) / Mst2, phospho (Thr180)

View all literature mentions

Phospho-Rb (Ser807/811) (D20B12) XP Rabbit mAb (antibody)

RRID:AB_11178658

This monoclonal targets Phospho-Rb (Ser807/811) (D20B12) XP Rabbit mAb

View all literature mentions

Phospho-LATS1 (Ser909) Antibody (antibody)

RRID:AB_2133515

This polyclonal targets Phospho-LATS1 (Ser909)

View all literature mentions

YAP (D8H1X) XP Rabbit mAb (antibody)

RRID:AB_2650491

This recombinant monoclonal targets YAP

View all literature mentions

Anti-CDK6 (antibody)

RRID:AB_1846432

This unknown targets CDK6

View all literature mentions

β-Catenin (D10A8) XP® Rabbit mAb (antibody)

RRID:AB_11127855

This monoclonal targets β-Catenin

View all literature mentions

HEK293T (cell line)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MCF-7 (cell line)

RRID:CVCL_0031

Cell line MCF-7 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

NOD.Cg-Prkdcscid Il2rg/SzJ (organism)

RRID:IMSR_JAX:005557

Mus musculus with name NOD.Cg-Prkdcscid Il2rg/SzJ from IMSR.

View all literature mentions

ZR-75-1 (cell line)

RRID:CVCL_0588

Cell line ZR-75-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

T-47D (cell line)

RRID:CVCL_0553

Cell line T-47D is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

β-Catenin (D10A8) XP® Rabbit mAb (antibody)

RRID:AB_11127855

This monoclonal targets β-Catenin

View all literature mentions

Beta-Tubulin Antibody (antibody)

RRID:AB_2210545

This polyclonal targets Beta-Tubulin

View all literature mentions

CDK4 (D9G3E) Rabbit mAb (antibody)

RRID:AB_2631166

This monoclonal targets CDK4

View all literature mentions

Anti-CDK6 (antibody)

RRID:AB_1846432

This unknown targets CDK6

View all literature mentions

β-Actin (13E5) Rabbit mAb (antibody)

RRID:AB_2223172

This monoclonal targets beta-Actin

View all literature mentions

LATS1 (C66B5) Rabbit mAb (antibody)

RRID:AB_2133513

This monoclonal targets LATS1

View all literature mentions

Survivin (71G4B7) Rabbit mAb (antibody)

RRID:AB_2063948

This recombinant monoclonal targets Survivin

View all literature mentions

YAP (D8H1X) XP Rabbit mAb (antibody)

RRID:AB_2650491

This recombinant monoclonal targets YAP

View all literature mentions

Anti-Mst1, phospho (Thr183) / Mst2, phospho (Thr180) Antibody, Unconjugated (antibody)

RRID:AB_330269

This unknown targets Mst1, phospho (Thr183) / Mst2, phospho (Thr180)

View all literature mentions

Phospho-Rb (Ser807/811) (D20B12) XP Rabbit mAb (antibody)

RRID:AB_11178658

This monoclonal targets Phospho-Rb (Ser807/811) (D20B12) XP Rabbit mAb

View all literature mentions

Phospho-LATS1 (Ser909) Antibody (antibody)

RRID:AB_2133515

This polyclonal targets Phospho-LATS1 (Ser909)

View all literature mentions

Phospho-Rb (Ser780) (D59B7) Rabbit mAb (antibody)

RRID:AB_10950972

This monoclonal targets Phospho-Rb (Ser780) (D59B7) Rabbit mAb

View all literature mentions

NOD.Cg-Prkdcscid Il2rg/SzJ (organism)

RRID:IMSR_JAX:005557

Mus musculus with name NOD.Cg-Prkdcscid Il2rg/SzJ from IMSR.

View all literature mentions

HEK293T (cell line)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

ZR-75-1 (cell line)

RRID:CVCL_0588

Cell line ZR-75-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MCF-7 (cell line)

RRID:CVCL_0031

Cell line MCF-7 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

T-47D (cell line)

RRID:CVCL_0553

Cell line T-47D is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions